These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24896625)

  • 1. Is there any relationship between gene expression of tumor antigens and CD4+ T cells in multiple myeloma?
    Braga WM; da Silva BR; Alves VL; Bortoluzo AB; Atanackovic D; Colleoni GW
    Immunotherapy; 2014; 6(5):569-75. PubMed ID: 24896625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.
    Atanackovic D; Luetkens T; Hildebrandt Y; Arfsten J; Bartels K; Horn C; Stahl T; Cao Y; Zander AR; Bokemeyer C; Kröger N
    Clin Cancer Res; 2009 Feb; 15(4):1343-52. PubMed ID: 19190130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients.
    Andrade VC; Vettore AL; Felix RS; Almeida MS; Carvalho F; Oliveira JS; Chauffaille ML; Andriolo A; Caballero OL; Zago MA; Colleoni GW
    Cancer Immun; 2008 Feb; 8():2. PubMed ID: 18237105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.
    Pabst C; Zustin J; Jacobsen F; Luetkens T; Kröger N; Schilling G; Bokemeyer C; Sauter G; Atanackovic D; Marx A
    Exp Mol Pathol; 2010 Oct; 89(2):175-81. PubMed ID: 20621094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
    Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
    Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation.
    Jungbluth AA; Ely S; DiLiberto M; Niesvizky R; Williamson B; Frosina D; Chen YT; Bhardwaj N; Chen-Kiang S; Old LJ; Cho HJ
    Blood; 2005 Jul; 106(1):167-74. PubMed ID: 15761016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapy.
    de Carvalho F; Vettore AL; Colleoni GW
    Clin Dev Immunol; 2012; 2012():257695. PubMed ID: 22481966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients.
    Nuber N; Curioni-Fontecedro A; Dannenmann SR; Matter C; von Boehmer L; Atanackovic D; Knuth A; van den Broek M
    Leukemia; 2013 Aug; 27(8):1767-9. PubMed ID: 23429573
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
    Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma.
    Schuberth PC; Jakka G; Jensen SM; Wadle A; Gautschi F; Haley D; Haile S; Mischo A; Held G; Thiel M; Tinguely M; Bifulco CB; Fox BA; Renner C; Petrausch U
    Gene Ther; 2013 Apr; 20(4):386-95. PubMed ID: 22739387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy.
    de Carvalho F; Alves VL; Braga WM; Xavier CV; Colleoni GW
    Cancer Immunol Immunother; 2013 Jan; 62(1):191-5. PubMed ID: 23180015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of antigen-specific T-cell responses with antigen expression and immunoparalysis in multiple myeloma.
    Fichtner S; Hose D; Engelhardt M; Meißner T; Neuber B; Krasniqi F; Raab M; Schönland S; Ho AD; Goldschmidt H; Hundemer M
    Clin Cancer Res; 2015 Apr; 21(7):1712-21. PubMed ID: 25609061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrence.
    Perez D; Herrmann T; Jungbluth AA; Samartzis P; Spagnoli G; Demartines N; Clavien PA; Marino S; Seifert B; Jaeger D
    Int J Cancer; 2008 Oct; 123(7):1551-5. PubMed ID: 18646188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.
    Milne K; Barnes RO; Girardin A; Mawer MA; Nesslinger NJ; Ng A; Nielsen JS; Sahota R; Tran E; Webb JR; Wong MQ; Wick DA; Wray A; McMurtrie E; Köbel M; Kalloger SE; Gilks CB; Watson PH; Nelson BH
    PLoS One; 2008; 3(10):e3409. PubMed ID: 18923710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
    Dhodapkar MV; Osman K; Teruya-Feldstein J; Filippa D; Hedvat CV; Iversen K; Kolb D; Geller MD; Hassoun H; Kewalramani T; Comenzo RL; Coplan K; Chen YT; Jungbluth AA
    Cancer Immun; 2003 Jul; 3():9. PubMed ID: 12875607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes encoding tumor-specific antigens are expressed in human myeloma cells.
    van Baren N; Brasseur F; Godelaine D; Hames G; Ferrant A; Lehmann F; André M; Ravoet C; Doyen C; Spagnoli GC; Bakkus M; Thielemans K; Boon T
    Blood; 1999 Aug; 94(4):1156-64. PubMed ID: 10438702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cancer testis antigens CT10 (MAGE-C2) and GAGE in gastrointestinal stromal tumors.
    Ghadban T; Perez DR; Vashist YK; Bockhorn M; Koenig AM; El Gammal AT; Izbicki JR; Metzger U; Hauswirth F; Frosina D; Jungbluth AA
    Eur J Surg Oncol; 2014 Oct; 40(10):1307-12. PubMed ID: 24713551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs.
    Taylor BJ; Reiman T; Pittman JA; Keats JJ; de Bruijn DR; Mant MJ; Belch AR; Pilarski LM
    J Immunother; 2005; 28(6):564-75. PubMed ID: 16224274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.